)
US: FDA approves first oral pill to treat postpartum depression
The United States Food and Drug Administration (FDA) on Friday (August 4) approved the use of the Zurzuvae (zuranolone) pill to treat postpartum depression (PPD) in adults. In a statement, the FDA said that the pill is to be taken once every day for 14 days during the evening with a fatty meal. The daily recommended dosage is 40 milligrams. The approval of Zurzuvae was granted to Sage Therapeutics, Inc, the statement added.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)